Caredx, INC Form 4 insider transactions

CareDx, Inc. Director Hannah Valantine reported the acquisition of 12,103 restricted stock units, increasing her beneficial ownership to 49,564 shares.

CareDx, Inc. Director Christine Cournoyer has reported the acquisition of 12,103 shares of common stock in the form of restricted stock units, increasing her beneficial ownership.

CareDx, Inc. Director Arthur Torres was granted 12,103 restricted stock units as part of his compensation, which are set to vest in 2026 or earlier.

CareDx, Inc. Director William A. Hagstrom executed a series of transactions on June 11, 2025, involving the exercise of stock options and the subsequent sale of common stock.

CareDx, Inc.'s Secretary and General Counsel, Jeffrey Adam Novack, reported the disposition of 2,583 shares of common stock on June 6, 2025, primarily to cover tax withholding obligations related to restricted stock unit vesting.

CareDx, Inc. Director William A. Hagstrom exercised stock options and subsequently sold 30,000 shares of common stock for approximately $523,413 on May 28, 2025.

CareDx, Inc.'s Chief Financial Officer, Abhishek Jain, reported the disposition of 1,982 shares of common stock valued at $17.63 per share to cover tax withholding obligations related to restricted stock unit vesting.

Christine Cournoyer, a director at CareDx, Inc., exercised stock options and sold shares of common stock on May 12, 2025.

Christine Cournoyer, a director of CareDx, Inc., sold 16,700 shares of common stock at an average price of $14.1275 on May 6, 2025.

CareDx's Secretary and General Counsel, Jeffrey Adam Novack, sold 2,688 shares of common stock at $14.7 per share on May 5, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., reported disposing of 2,873 shares of common stock to cover tax withholding obligations.

Abhishek Jain, CFO of CareDx, Inc., reports the disposal of 7,686 shares of common stock to cover tax obligations related to vesting restricted stock units.

Peter Maag, a director at CareDx, Inc., sold 13,281 shares of common stock on April 30, 2025, at a weighted average price of $17.2273 per share, according to a Form 4 filing with the SEC.

Abhishek Jain, CFO of CareDx, Inc., reports the withholding of 338 common stock shares to cover tax obligations related to vesting restricted stock units on April 21, 2025.

CareDx's CEO, John Walter Hanna Jr., reports the disposition of 61,469 shares of common stock to cover tax obligations related to vesting restricted stock units.

Abhishek Jain, CFO of CareDx, Inc., sold 265 shares of common stock on April 7, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., reported selling 924 shares of common stock on April 7, 2025, to cover tax withholding obligations.

Director Michael Goldberg acquired 967 shares of CareDx, Inc. common stock on April 4, 2025, through an automatic quarterly grant in lieu of cash compensation.

Jessica Meng, Chief Commercial Officer of CareDx, Inc., reports the acquisition of 61,756 restricted stock units.

CareDx's Chief Operating Officer, Keith Kennedy, reported the acquisition and disposal of company stock, including restricted stock units, in a recent SEC filing.

CareDx's Chief Financial Officer, Abhishek Jain, reported acquiring 55,580 shares of common stock on March 21, 2025, through restricted stock units.

Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., reports acquiring and disposing of common stock and restricted stock units.

CareDx CEO John Walter Hanna Jr. reports the acquisition of 200,706 restricted stock units and the disposal of 688,510 common stock shares on March 21, 2025.

Director George Bickerstaff of CareDx, Inc. sold 20,000 shares of common stock on March 10, 2025, at a weighted average price of $18.3551.

CareDx's CFO, Abhishek Jain, reports the acquisition and disposal of company stock related to performance restricted stock units.

Abhishek Jain, CFO of CareDx, Inc., disposed of 11,244 shares of common stock on February 3, 2025, to cover tax obligations related to vesting restricted stock units.

CareDx's Secretary and General Counsel, Jeffrey Adam Novack, reports the disposition of company stock to cover tax obligations and sales under a pre-arranged trading plan.

Director Michael Goldberg acquired 856 shares of CareDx, Inc. common stock on January 6, 2025, through an automatic quarterly grant in lieu of cash compensation.

CareDx's Secretary and General Counsel, Jeffrey Adam Novack, sold 1,917 shares of common stock at $26 per share under a pre-arranged 10b5-1 trading plan.

CareDx director Peter Maag exercised stock options and sold 5,000 shares of common stock on November 26, 2024, under a pre-arranged 10b5-1 trading plan.